{"id":"https://openalex.org/W4402011173","doi":"https://doi.org/10.1186/s12936-024-05088-6","title":"Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers","display_name":"Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers","publication_year":2024,"publication_date":"2024-08-29","ids":{"openalex":"https://openalex.org/W4402011173","doi":"https://doi.org/10.1186/s12936-024-05088-6","pmid":"https://pubmed.ncbi.nlm.nih.gov/39210367","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11360866"},"language":"en","primary_location":{"id":"doi:10.1186/s12936-024-05088-6","doi":"https://doi.org/10.1186/s12936-024-05088-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12936-024-05088-6","pdf_url":"https://malariajournal.biomedcentral.com/counter/pdf/10.1186/s12936-024-05088-6","source":{"id":"https://openalex.org/S93003929","display_name":"Malaria Journal","issn_l":"1475-2875","issn":["1475-2875"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Malaria Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://malariajournal.biomedcentral.com/counter/pdf/10.1186/s12936-024-05088-6","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045428935","display_name":"Kolapo Muyiwa Oyebola","orcid":"https://orcid.org/0000-0002-1003-2570","observed_orcids":["https://orcid.org/0000-0002-1003-2570"]},"institutions":[{"id":"https://openalex.org/I4210092144","display_name":"Mountain Top University","ror":"https://ror.org/00effsg46","country_code":"NG","type":"education","lineage":["https://openalex.org/I4210092144"]},{"id":"https://openalex.org/I49433721","display_name":"Nigerian Institute of Medical Research","ror":"https://ror.org/03kk9k137","country_code":"NG","type":"healthcare","lineage":["https://openalex.org/I49433721"]}],"countries":["NG"],"is_corresponding":true,"raw_author_name":"Kolapo M. Oyebola","raw_affiliation_strings":["Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria. oyebolakolapo@yahoo.com","Nigerian Institute of Medical Research, Lagos, Nigeria. oyebolakolapo@yahoo.com","Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria. oyebolakolapo@yahoo.com","institution_ids":["https://openalex.org/I4210092144"]},{"raw_affiliation_string":"Nigerian Institute of Medical Research, Lagos, Nigeria. oyebolakolapo@yahoo.com","institution_ids":["https://openalex.org/I49433721"]},{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","institution_ids":["https://openalex.org/I4210092144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073765553","display_name":"Funmilayo C. Ligali","orcid":"https://orcid.org/0009-0007-6114-6715","observed_orcids":["https://orcid.org/0009-0007-6114-6715"]},"institutions":[{"id":"https://openalex.org/I4210092144","display_name":"Mountain Top University","ror":"https://ror.org/00effsg46","country_code":"NG","type":"education","lineage":["https://openalex.org/I4210092144"]},{"id":"https://openalex.org/I49433721","display_name":"Nigerian Institute of Medical Research","ror":"https://ror.org/03kk9k137","country_code":"NG","type":"healthcare","lineage":["https://openalex.org/I49433721"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Funmilayo C. Ligali","raw_affiliation_strings":["Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","Nigerian Institute of Medical Research, Lagos, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","institution_ids":["https://openalex.org/I4210092144"]},{"raw_affiliation_string":"Nigerian Institute of Medical Research, Lagos, Nigeria","institution_ids":["https://openalex.org/I49433721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023235906","display_name":"Afolabi J. Owoloye","orcid":"https://orcid.org/0000-0003-2446-4769","observed_orcids":["https://orcid.org/0000-0003-2446-4769"]},"institutions":[{"id":"https://openalex.org/I4210092144","display_name":"Mountain Top University","ror":"https://ror.org/00effsg46","country_code":"NG","type":"education","lineage":["https://openalex.org/I4210092144"]},{"id":"https://openalex.org/I49433721","display_name":"Nigerian Institute of Medical Research","ror":"https://ror.org/03kk9k137","country_code":"NG","type":"healthcare","lineage":["https://openalex.org/I49433721"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Afolabi J. Owoloye","raw_affiliation_strings":["Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","Nigerian Institute of Medical Research, Lagos, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","institution_ids":["https://openalex.org/I4210092144"]},{"raw_affiliation_string":"Nigerian Institute of Medical Research, Lagos, Nigeria","institution_ids":["https://openalex.org/I49433721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111140009","display_name":"Oluwagbemiga Olanrewaju Aina","orcid":"https://orcid.org/0000-0002-0795-4785","observed_orcids":["https://orcid.org/0000-0002-0795-4785"]},"institutions":[{"id":"https://openalex.org/I49433721","display_name":"Nigerian Institute of Medical Research","ror":"https://ror.org/03kk9k137","country_code":"NG","type":"healthcare","lineage":["https://openalex.org/I49433721"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Oluwagbemiga O. Aina","raw_affiliation_strings":["Nigerian Institute of Medical Research, Lagos, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nigerian Institute of Medical Research, Lagos, Nigeria","institution_ids":["https://openalex.org/I49433721"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052218813","display_name":"Yetunde Mary Alo","orcid":"https://orcid.org/0000-0002-1400-5158","observed_orcids":["https://orcid.org/0000-0002-1400-5158"]},"institutions":[{"id":"https://openalex.org/I4210092144","display_name":"Mountain Top University","ror":"https://ror.org/00effsg46","country_code":"NG","type":"education","lineage":["https://openalex.org/I4210092144"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Yetunde M. Alo","raw_affiliation_strings":["Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","institution_ids":["https://openalex.org/I4210092144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066258992","display_name":"Blessing Erinwusi","orcid":"https://orcid.org/0000-0002-3920-7610","observed_orcids":["https://orcid.org/0000-0002-3920-7610"]},"institutions":[{"id":"https://openalex.org/I4210092144","display_name":"Mountain Top University","ror":"https://ror.org/00effsg46","country_code":"NG","type":"education","lineage":["https://openalex.org/I4210092144"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Blessing Erinwusi","raw_affiliation_strings":["Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","institution_ids":["https://openalex.org/I4210092144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072120407","display_name":"Michael Olufemi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092144","display_name":"Mountain Top University","ror":"https://ror.org/00effsg46","country_code":"NG","type":"education","lineage":["https://openalex.org/I4210092144"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Michael J. Olufemi","raw_affiliation_strings":["Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Genomic Research in Biomedicine, Mountain Top University, Ibafo, Nigeria","institution_ids":["https://openalex.org/I4210092144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077699808","display_name":"Babatunde Lawal Salako","orcid":"https://orcid.org/0000-0002-0963-7302","observed_orcids":["https://orcid.org/0000-0002-0963-7302"]},"institutions":[{"id":"https://openalex.org/I49433721","display_name":"Nigerian Institute of Medical Research","ror":"https://ror.org/03kk9k137","country_code":"NG","type":"healthcare","lineage":["https://openalex.org/I49433721"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"Babatunde L. Salako","raw_affiliation_strings":["Nigerian Institute of Medical Research, Lagos, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nigerian Institute of Medical Research, Lagos, Nigeria","institution_ids":["https://openalex.org/I49433721"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045428935"],"corresponding_institution_ids":["https://openalex.org/I4210092144","https://openalex.org/I49433721"],"apc_list":{"value":2790,"currency":"USD","value_usd":2790},"apc_paid":{"value":2790,"currency":"USD","value_usd":2790},"fwci":4.83,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.95992937,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"23","issue":"1","first_page":"261","last_page":"261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12685","display_name":"Phytochemical compounds biological activities","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/artemether-lumefantrine","display_name":"artemether-lumefantrine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/uncomplicated-malaria","display_name":"uncomplicated malaria","score":0.9739999771118164},{"id":"https://openalex.org/keywords/plasmodium-falciparum","display_name":"Plasmodium falciparum","score":0.996999979019165},{"id":"https://openalex.org/keywords/antimalarial-drug-resistance","display_name":"antimalarial drug resistance","score":0.7509999871253967},{"id":"https://openalex.org/keywords/artemisinin-resistance","display_name":"artemisinin resistance","score":0.902999997138977},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7760000228881836},{"id":"https://openalex.org/keywords/parasite-clearance","display_name":"parasite clearance","score":0.8080000281333923},{"id":"https://openalex.org/keywords/merozoite-surface-protein-1","display_name":"merozoite surface protein 1","score":0.7429999709129333},{"id":"https://openalex.org/keywords/msp2","display_name":"msp2","score":0.9900000095367432},{"id":"https://openalex.org/keywords/genetic-diversity","display_name":"genetic diversity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/multiplicity-of-infection","display_name":"multiplicity of infection","score":0.9679999947547913},{"id":"https://openalex.org/keywords/polyclonal-infection","display_name":"polyclonal infection","score":0.7289999723434448},{"id":"https://openalex.org/keywords/lagos","display_name":"Lagos","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C2778629330","wikidata":"https://www.wikidata.org/wiki/Q904464","display_name":"Artemether/lumefantrine","level":5,"score":0.9369043111801147},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.7882524728775024},{"id":"https://openalex.org/C2778118209","wikidata":"https://www.wikidata.org/wiki/Q416199","display_name":"Artemether","level":5,"score":0.7178812623023987},{"id":"https://openalex.org/C185032368","wikidata":"https://www.wikidata.org/wiki/Q1365243","display_name":"Tropical medicine","level":2,"score":0.7171198129653931},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.649795651435852},{"id":"https://openalex.org/C190612196","wikidata":"https://www.wikidata.org/wiki/Q180502","display_name":"Parasitology","level":2,"score":0.6461285948753357},{"id":"https://openalex.org/C190139176","wikidata":"https://www.wikidata.org/wiki/Q598976","display_name":"Medical microbiology","level":2,"score":0.511459231376648},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5074741244316101},{"id":"https://openalex.org/C2780780316","wikidata":"https://www.wikidata.org/wiki/Q904464","display_name":"Lumefantrine","level":5,"score":0.4254891276359558},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35254502296447754},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.3487510681152344},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.34576189517974854},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3220953941345215},{"id":"https://openalex.org/C2776120307","wikidata":"https://www.wikidata.org/wiki/Q426921","display_name":"Artemisinin","level":4,"score":0.2949799597263336},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2717456817626953},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2662631869316101},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13183638453483582},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.09853601455688477}],"mesh":[{"descriptor_ui":"D000077611","descriptor_name":"Artemether, Lumefantrine Drug Combination","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005449","descriptor_name":"Fluorenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009549","descriptor_name":"Nigeria","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D014644","descriptor_name":"Genetic Variation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016778","descriptor_name":"Malaria, Falciparum","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016778","descriptor_name":"Malaria, Falciparum","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020066","descriptor_name":"Merozoite Surface Protein 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D037621","descriptor_name":"Artemisinins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D037621","descriptor_name":"Artemisinins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s12936-024-05088-6","doi":"https://doi.org/10.1186/s12936-024-05088-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12936-024-05088-6","pdf_url":"https://malariajournal.biomedcentral.com/counter/pdf/10.1186/s12936-024-05088-6","source":{"id":"https://openalex.org/S93003929","display_name":"Malaria Journal","issn_l":"1475-2875","issn":["1475-2875"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Malaria Journal","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-3985557/v1","doi":"https://doi.org/10.21203/rs.3.rs-3985557/v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21203/rs.3.rs-3985557/v1","pdf_url":"https://www.researchsquare.com/article/rs-3985557/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:11360866","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11360866","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11360866/pdf/12936_2024_Article_5088.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Malar J","raw_type":"Text"},{"id":"pmid:39210367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39210367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Malaria journal","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:a3b7a6b09d1d401fa9dca822ba9e5481","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/a3b7a6b09d1d401fa9dca822ba9e5481","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Malaria Journal, Vol 23, Iss 1, Pp 1-11 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12936-024-05088-6","doi":"https://doi.org/10.1186/s12936-024-05088-6","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12936-024-05088-6","pdf_url":"https://malariajournal.biomedcentral.com/counter/pdf/10.1186/s12936-024-05088-6","source":{"id":"https://openalex.org/S93003929","display_name":"Malaria Journal","issn_l":"1475-2875","issn":["1475-2875"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Malaria Journal","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1458299293","display_name":"Investigating artemisinin resistance in Nigerian isolates of Plasmodium falciparum","funder_award_id":"TMA2019CDF-2782","funder_id":"https://openalex.org/F4320338462","funder_display_name":"European and Developing Countries Clinical Trials Partnership"}],"funders":[{"id":"https://openalex.org/F4320338462","display_name":"European and Developing Countries Clinical Trials Partnership","ror":"https://ror.org/031jv9v19"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402011173.pdf","grobid_xml":"https://content.openalex.org/works/W4402011173.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W2069995906","https://openalex.org/W2122781626","https://openalex.org/W2126005238","https://openalex.org/W2168824507","https://openalex.org/W2506210560","https://openalex.org/W2805681996","https://openalex.org/W2954093007","https://openalex.org/W2980881940","https://openalex.org/W2984182550","https://openalex.org/W3001008900","https://openalex.org/W3030594277","https://openalex.org/W3031413726","https://openalex.org/W3136406435","https://openalex.org/W3141886345","https://openalex.org/W3144373842","https://openalex.org/W3154684688","https://openalex.org/W3159783306","https://openalex.org/W3166773630","https://openalex.org/W3176606269","https://openalex.org/W3185470179","https://openalex.org/W4210365244","https://openalex.org/W4214687308","https://openalex.org/W4225285081","https://openalex.org/W4225546353","https://openalex.org/W4293447100","https://openalex.org/W4311450992","https://openalex.org/W4387666454","https://openalex.org/W4391379888"],"related_works":["https://openalex.org/W4396851137","https://openalex.org/W4392409701","https://openalex.org/W7221297186","https://openalex.org/W6957741815","https://openalex.org/W2165552432","https://openalex.org/W1496593134","https://openalex.org/W3082669466","https://openalex.org/W2996445813","https://openalex.org/W4402603857","https://openalex.org/W7117483204"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,114,142,245],"burden":[2],"of":[3,12,24,40,46,60,107,116,184,215,250,267,273,285],"malaria":[4,28,62],"persists":[5],"in":[6,50,67,176,225,289],"sub-Saharan":[7],"Africa":[8],"and":[9,43,81,88,96,112,150,154,170,191,208],"the":[10,22,178,221,226,271,283,290],"emergence":[11],"artemisinin":[13],"resistance":[14,118,126,288],"has":[15],"introduced":[16],"complexity":[17],"to":[18,31],"control":[19],"efforts.":[20],"Monitoring":[21],"efficacy":[23,39,249],"artemisinin-based":[25],"treatment":[26,38,144],"for":[27,72,91,187,205,210,252,282],"is":[29],"crucial":[30],"address":[32],"this":[33],"challenge.":[34],"This":[35],"study":[36,246],"assessed":[37,100,121],"artemether-lumefantrine":[41],"(AL)":[42],"genetic":[44,97],"diversity":[45,98,198,259],"Plasmodium":[47],"falciparum":[48,124,134,256],"isolates":[49],"a":[51,64,181,240,274],"Nigerian":[52],"population.":[53,291],"METHODS:":[54],"Participants":[55],"presenting":[56],"with":[57,79,220],"clinical":[58,87,149],"symptoms":[59],"uncomplicated":[61,254],"at":[63,239],"health":[65],"centre":[66],"Lagos,":[68],"Nigeria,":[69],"were":[70,77,99],"screened":[71],"P.":[73,123,133,255],"falciparum.":[74],"Enrolled":[75],"participants":[76],"treated":[78],"AL":[80,251],"monitored":[82],"through":[83,101],"scheduled":[84],"check-up":[85],"visits,":[86],"laboratory":[89],"examinations":[90],"28":[92],"days.":[93],"Parasite":[94],"clearance":[95],"polymerase":[102],"chain":[103],"reaction":[104],"(PCR)":[105],"analysis":[106,199,233,260],"merozoite":[108],"surface":[109],"proteins":[110],"(msp1":[111],"msp2).":[113],"prevalence":[115,183],"drug":[117,287],"mutations":[119],"was":[120,168,174,195,218],"by":[122,132],"multidrug":[125],"gene":[127,139],"1":[128,137],"(mdr1)":[129],"genotyping":[130],"followed":[131],"ubiquitin-specific":[135],"protease":[136],"(ubp1)":[138],"sequencing.":[140],"RESULTS:":[141],"PCR-uncorrected":[143],"outcome":[145],"revealed":[146,200,261],"94.4%":[147],"adequate":[148],"parasitological":[151,157],"response":[152],"(ACPR)":[153],"5.6%":[155],"late":[156],"failure":[158],"(LPF)":[159],"rates.":[160],"After":[161],"PCR":[162],"correction,":[163],"no":[164],"suspected":[165],"LPF":[166],"case":[167],"detected":[169],"ACPR":[171],"67/67":[172],"(100%)":[173],"achieved":[175],"all":[177],"individuals.":[179],"Moreover,":[180],"high":[182],"wild-type":[185],"alleles":[186],"mdr1":[188,192],"N86Y":[189],"(93.7%),":[190],"D1246Y":[193],"(87.5%)":[194],"observed.":[196],"Genetic":[197,258],"predominant":[201],"K1":[202],"allelic":[203,263],"family":[204],"msp1":[206],"(90.2%)":[207],"FC27":[209],"msp2":[211],"(64.4%).":[212],"Estimated":[213],"multiplicity":[214],"infection":[216],"(MOI)":[217],"1.7,":[219],"highest":[222],"MOI":[223],"observed":[224],"5-15":[227],"years":[228],"age":[229],"group.":[230],"ubp1":[231,276],"sequence":[232],"identified":[234],"one":[235],"nonsynonymous":[236],"E1528D":[237],"polymorphism":[238,277],"low":[241],"frequency":[242],"(1.6%).":[243],"CONCLUSION:":[244],"demonstrated":[247],"sustained":[248],"treating":[253],"malaria.":[257],"various":[262],"types,":[264],"suggesting":[265],"occurrences":[266],"polyclonal":[268],"infections.":[269],"Nonetheless,":[270],"detection":[272],"significant":[275],"could":[278],"have":[279],"future":[280],"implications":[281],"epidemiology":[284],"anti-malarial":[286]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":7}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-08-30T00:00:00"}